Skip to main content
Theodora Ross, MD, Oncology, Dallas, TX, William P. Clements, Jr. University Hospital

TheodoraSuzanneRossMD

Oncology Dallas, TX

Breast Cancer, Cancer Genetics/Cancer Risk Assessment, Gynecologic Cancer, Hematologic Oncology

Professor, Internal Medicine, University of Texas Southwestern Medical Center, Southwestern Medical School

Dr. Ross is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Ross' full profile

Already have an account?

Education & Training

  • Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer Institute
    Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1995 - 1998
  • Brigham and Women's Hospital
    Brigham and Women's HospitalResidency, Internal Medicine, 1993 - 1995
  • Washington University in St. Louis School of Medicine
    Washington University in St. Louis School of MedicineClass of 1993
  • Kalamazoo College
    Kalamazoo CollegeBA, Biology, Summa Cum Laude, 1986

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2012 - 2025
  • MI State Medical License
    MI State Medical License 1999 - 2015

Awards, Honors, & Recognition

  • Medical Student Award for Excellence American Federation for Clinical Research, 0
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
  • Clinical Scientist Award Burroughs Wellcome Fund, 2008
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Prevalence of Variant Reclassification Following Hereditary Cancer Genetic Testing  
    Theodora Ross, MD, JAMA
  • Regulation of the Src homology 2-containing inositol 5-phosphatase SHIP1 in HIP1/ PDGFbetaR transformed cells  
    Saint-Dic J, Chang SC, Taylor GS, Provot MM, Ross TS, J Biol Chem, 1/1/2001
  • Transformation of hematopoietic cell lines to growth-factor independence and induction of a fatal myelo- and lyphoproliferative disease in mice by retrovirally transdu...  
    Schwaller J, Frantsve J, Aster J, Williams IR, Tomasson MH, Ross TS, Peeters P, Van Rompaey L, Van Etten RA, Ilaria R Jr, Marynen P, Gilliland DG, EMBO J, 1/1/1998
  • Join now to see all

Lectures

  • Celebrate your survivor genes: Cancer Genomic Research 
    11/1/2014
  • The Power of Genetics: Preventing and Knowing Cancer 
    UT Southwestern Medical Center, Dallas, TX - 9/1/2014
  • The Cancer Genetics Clinic of the Future 
    Moncrief Cancer Institute, Ft. Worth, TX - 8/1/2014
  • Join now to see all

Press Mentions

  • Is Cancer Hereditary? Everything You Need to Know
    Is Cancer Hereditary? Everything You Need to KnowSeptember 15th, 2020
  • AACC: Labs Grapple with 'Double-Edged Sword' of Direct-to-Consumer Testing
    AACC: Labs Grapple with 'Double-Edged Sword' of Direct-to-Consumer TestingAugust 5th, 2019
  • The Results of Your Genetic Test Are Reassuring. But That Can Change
    The Results of Your Genetic Test Are Reassuring. But That Can ChangeOctober 16th, 2018
  • Join now to see all

Grant Support

  • Huntington Interacting Protein-1(Hip1) And The Promotion Of NeoplasiaNational Cancer Institute2012
  • Huntington Interacting Protein-1(Hip1) And The Promotion Of NeoplasiaNational Cancer Institute2008–2011
  • HIP1 And The Promotion Of NeoplasiaNational Cancer Institute2003–2007
  • Mechanism Of Transformation By Hip1/PdgfbrNational Cancer Institute2000–2004
  • Novel Fusion Protein In CMMLNational Cancer Institute1999–2002
  • Novel Fusion Protein In CMMLNational Cancer Institute1998–1999

Hospital Affiliations